Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(Q1)Oct 31, 2024 | (FY)Jul 31, 2024 | (Q4)Jul 31, 2024 | (Q3)Apr 30, 2024 | (Q2)Jan 31, 2024 | (Q1)Oct 31, 2023 | (FY)Jul 31, 2023 | (Q4)Jul 31, 2023 | (Q3)Apr 30, 2023 | (Q2)Jan 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -4.08%10B | 1.41%42.41B | 6.55%10.87B | 1.64%11.5B | -7.63%9.62B | 5.36%10.42B | 6.82%41.82B | -5.72%10.2B | 8.12%11.32B | 19.83%10.41B |
Cost of revenue | -0.78%7.66B | -0.26%31.23B | 6.44%8.25B | 0.93%8.38B | -15.30%6.88B | 8.21%7.72B | 6.05%31.31B | -4.02%7.75B | 6.82%8.3B | 20.59%8.12B |
Gross profit | -13.52%2.34B | 6.38%11.18B | 6.90%2.62B | 3.59%3.12B | 19.60%2.74B | -2.01%2.7B | 9.21%10.51B | -10.71%2.45B | 11.85%3.01B | 17.20%2.29B |
Operating expense | -5.12%2B | 4.64%8.12B | 9.08%2.12B | 1.59%1.91B | 0.92%1.97B | 6.84%2.11B | 0.30%7.76B | -3.70%1.95B | 0.93%1.88B | 4.06%1.95B |
Operating profit | -43.43%334.98M | 11.28%3.06B | -1.55%494.47M | 6.94%1.21B | 126.55%771.05M | -24.34%592.13M | 45.65%2.75B | -30.38%502.23M | 36.50%1.13B | 322.89%340.34M |
Net non-operating interest income (expenses) | 123.42%5.24M | 37.82%10.73M | 38.56%3.13M | 52.95%2.59M | 28.45%2.66M | 33.33%2.34M | 14.12%7.78M | 2.45%2.26M | 22.81%1.7M | 14.40%2.07M |
Non-operating interest income | 101.97%5.24M | 31.50%11.11M | 38.56%3.13M | 27.98%2.73M | 28.45%2.66M | 30.43%2.59M | 13.79%8.45M | 2.45%2.26M | 21.44%2.13M | 14.40%2.07M |
Non-operating interest expense | --0 | -42.62%381K | --0 | -69.59%132K | --0 | 8.26%249K | 10.12%664K | --0 | 16.35%434K | --0 |
Net investment income | 14.15%952K | 7.78%10.89M | 21.53%6.27M | 0.00%503K | -14.43%3.28M | 37.85%834K | -10.18%10.11M | -12.16%5.16M | 51.51%503K | -12.09%3.84M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | 0 | 48.08M | 0 | 0 | 41.89M | 6.19M | 0 | 0 | 0 | 0 |
Income from associates and other participating interests | ||||||||||
Special income (charges) | -14.77%40.89M | 1,683.76%222.57M | -200.25%-8.87M | 168.57%75.39M | 140.67%108.08M | 13.85%47.98M | -109.14%-14.05M | 183.87%8.85M | -248.68%-109.95M | -1.38%44.91M |
Less:Other special charges | 14.77%-40.89M | -5,079.13%-281.23M | -211.17%-49.79M | -168.57%-75.39M | -109.93%-108.08M | -0.16%-47.98M | 97.35%-5.43M | 30.35%-16M | 248.68%109.95M | 18.72%-51.48M |
Less:Write off | ---- | 201.09%58.66M | 720.66%58.66M | --0 | --0 | --0 | -62.04%19.48M | -78.68%7.15M | --0 | --6.58M |
Other non-operating income (expenses) | -14.39%34.28M | -16.95%117.38M | 23.12%38.48M | -97.83%953K | 11.96%37.91M | 23.70%40.04M | 19.53%141.34M | 45.97%31.25M | 36.08%43.86M | 5.82%33.86M |
Income before tax | -39.62%416.34M | 19.84%3.47B | -2.96%533.47M | 20.81%1.29B | 127.02%964.88M | -19.78%689.52M | 32.94%2.9B | -25.74%549.75M | 13.91%1.07B | 158.85%425.02M |
Income tax | -36.89%146.05M | 11.24%1.03B | -35.02%103.98M | 19.32%411.17M | 103.20%286.36M | -18.24%231.44M | 40.68%928.61M | -9.62%160.03M | 14.94%344.58M | 141.11%140.93M |
Net income | -41.00%270.28M | 23.89%2.44B | 10.20%429.49M | 21.52%875.57M | 138.83%678.51M | -20.53%458.08M | 29.57%1.97B | -30.81%389.72M | 13.43%720.51M | 168.66%284.1M |
Net income continuous operations | -41.00%270.28M | 23.89%2.44B | 10.20%429.49M | 21.52%875.57M | 138.83%678.51M | -20.53%458.08M | 29.57%1.97B | -30.81%389.72M | 13.43%720.51M | 168.66%284.09M |
Noncontrolling interests | ||||||||||
Net income attributable to the company | -41.00%270.28M | 23.89%2.44B | 10.20%429.49M | 21.52%875.57M | 138.83%678.51M | -20.53%458.08M | 29.57%1.97B | -30.81%389.72M | 13.43%720.51M | 168.66%284.1M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | -41.00%270.28M | 23.89%2.44B | 10.20%429.49M | 21.52%875.57M | 138.83%678.51M | -20.53%458.08M | 29.57%1.97B | -30.81%389.72M | 13.43%720.51M | 168.66%284.1M |
Gross dividend payment | ||||||||||
Basic earnings per share | -39.62%16.78 | 24.57%148.91 | 13.24%26.77 | 21.78%53.22 | 138.57%41.13 | -20.51%27.79 | 29.51%119.54 | -30.82%23.64 | 13.36%43.7 | 168.54%17.24 |
Diluted earnings per share | -39.62%16.78 | 24.57%148.91 | 12.81%26.6666 | 22.74%53.22 | 140.32%41.0868 | -20.51%27.79 | 29.51%119.54 | -30.81%23.6395 | 12.48%43.3603 | 166.31%17.097 |
Dividend per share | 0 | 23.08%32 | 23.08%16 | 0 | 23.08%16 | 0 | 0.00%26 | 0.00%13 | 0 | 0.00%13 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |